Acumen Pharmaceuticals In... (ABOS)

AI Score

Unlock

1.00

-0.02 (-1.96%)

At close: Apr 24, 2025, 9:50 AM

Acumen Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	290K	290K	290K	290K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.44M	2.17M	2.32M	2.54M	1.11M	377K	226K
Cost of Revenue	89K	128K	168K	176K	184K	194K	198K	184K	169K	123K	80K	2.29M	4.79M	5.81M	8.8M	8.48M	8M	6.97M	3.98M	2.05M
Gross Profit	-89K	162K	122K	114K	106K	-194K	-198K	-184K	-169K	-123K	-80K	-2.29M	-4.79M	-4.38M	-6.64M	-6.16M	-5.45M	-5.86M	-3.6M	-1.82M
Operating Income	-114.02M	-92.91M	-76.68M	-65.78M	-61.14M	-56.9M	-52.23M	-49.16M	-45.24M	-39.4M	-31.97M	-25M	-19.58M	-12.51M	-11.06M	-9.66M	-7.91M	-6.57M	-4.08M	-2.05M
Interest Income	14.32M	15.28M	14.9M	12.96M	10.79M	8.23M	5.77M	4.15M	2.39M	1.04M	412K	156K	84K	45K	8K	4K	1K	1K	1K	1K
Pretax Income	-102.33M	-81.67M	-64.86M	-55.94M	-52.37M	-48.74M	-46.49M	-45.03M	-42.86M	-38.34M	-31.53M	-82.74M	-100.61M	-93.01M	-91.6M	-32.28M	-7.33M	-6.57M	-4.08M	-2.04M
Net Income	-102.33M	-81.67M	-64.86M	-55.94M	-50.54M	-47.91M	-45M	-43.28M	-42.86M	-37.34M	-31.19M	-82.66M	-100.61M	-93.01M	-91.6M	-32.28M	-7.33M	-6.57M	-4.08M	-2.04M
Selling & General & Admin	20.22M	20.34M	20.19M	19.68M	18.78M	17.13M	15.33M	14.08M	12.88M	12.12M	11.19M	9.29M	7.28M	5.18M	3.27M	2.34M	1.35M	707K	481K	222K
Research & Development	93.8M	72.52M	56.45M	46.05M	42.32M	39.77M	36.9M	35.09M	32.36M	27.29M	20.78M	15.71M	12.3M	7.66M	8.85M	8.53M	8M	6.97M	3.98M	2.05M
Other Expenses	-54K	-75K	-117K	-133K	-83K	-72K	-32K	-16K	-11K	3K	24K	43K	51K	1.15M	1.14M	1.12M	1.11M	n/a	n/a	n/a
Operating Expenses	114.02M	92.87M	76.64M	65.74M	61.1M	56.9M	52.23M	49.16M	45.24M	39.4M	31.97M	25M	19.58M	13.95M	12.5M	11.25M	9.72M	6.95M	4.46M	2.27M
Interest Expense	4.07M	3.61M	2.58M	1.58M	581K	n/a	663K	663K	739K	739K	99K	99K	23K	23K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-39K	-39K	-39K	-39K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	114.02M	92.91M	76.68M	65.78M	61.14M	56.9M	52.23M	49.16M	45.24M	39.4M	31.97M	25M	19.58M	13.95M	12.5M	11.25M	9.72M	6.95M	4.46M	2.27M
Income Tax Expense	-44K	3.71M	3.67M	1.78M	n/a	-2.75M	-3.38M	-1.75M	n/a	-1.06M	-459K	57.72M	81M	80.48M	78.05M	18.09M	-5.11M	-4.53M	-2.04M	-1K
Shares Outstanding (Basic)	60.05M	60.08M	60.08M	59.81M	57.91M	54.23M	41.03M	41.03M	40.86M	40.5M	40.5M	40.47M	38.27M	38.27M	38.65M	36.99M	28.65M	28.65M	28.65M	28.65M
Shares Outstanding (Diluted)	60.05M	60.08M	60.08M	59.81M	57.91M	54.23M	41.03M	41.03M	40.86M	40.5M	40.5M	40.47M	38.27M	38.27M	38.65M	36.99M	28.65M	28.65M	28.65M	28.65M
EPS (Basic)	-1.71	-1.37	-1.11	-1.05	-1.03	-1.09	-1.1	-1.06	-1.05	-0.93	-0.78	-2.13	-2.64	-2.45	-2.43	-0.91	-0.26	-0.23	-0.14	-0.07
EPS (Diluted)	-1.71	-1.37	-1.11	-1.05	-1.03	-1.09	-1.1	-1.06	-1.05	-0.93	-0.78	-2.13	-2.64	-2.45	-2.43	-0.91	-0.26	-0.23	-0.14	-0.07
EBITDA	-98.08M	-75.48M	-62.83M	-54.9M	-52.32M	-53.09M	-48.42M	-47.27M	-45.19M	-39.32M	-31.88M	-24.91M	-19.54M	-12.51M	-11.07M	-9.66M	-5.87M	-4.52M	-2.03M	1K
EBIT	-98.26M	-78.06M	-65.36M	-57.44M	-54.87M	-53.2M	-48.54M	-47.34M	-45.24M	41.66M	49.1M	56.07M	61.48M	-12.51M	-11.07M	-9.66M	-7.91M	-6.57M	-4.08M	-2.05M
Depreciation & Amortization	178K	173K	168K	176K	184K	194K	198K	184K	169K	123K	80K	3.48M	7.24M	8.58M	11.06M	9.66M	7.91M	6.57M	4.08M	2.05M